GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,925,000 | +47.6% | 365,875 | +47.7% | 0.08% | +63.5% |
| Q1 2022 | $10,792,000 | +4.0% | 247,754 | +5.3% | 0.05% | +8.3% |
| Q4 2021 | $10,379,000 | +28.6% | 235,377 | +11.4% | 0.05% | +14.3% |
| Q3 2021 | $8,073,000 | +7.2% | 211,308 | +11.7% | 0.04% | 0.0% |
| Q2 2021 | $7,531,000 | +56.7% | 189,130 | +40.4% | 0.04% | +27.3% |
| Q1 2021 | $4,805,000 | +5.7% | 134,667 | +9.0% | 0.03% | -2.9% |
| Q4 2020 | $4,546,000 | -95.7% | 123,587 | -95.6% | 0.03% | -96.6% |
| Q3 2020 | $105,786,000 | -8.1% | 2,810,528 | -0.4% | 0.99% | -17.7% |
| Q2 2020 | $115,094,000 | -20.5% | 2,821,629 | -26.1% | 1.20% | -36.6% |
| Q1 2020 | $144,716,000 | +12195.3% | 3,819,379 | +15141.5% | 1.90% | +12553.3% |
| Q4 2019 | $1,177,000 | +14.4% | 25,059 | +3.9% | 0.02% | +7.1% |
| Q3 2019 | $1,029,000 | +13.8% | 24,126 | +6.8% | 0.01% | +7.7% |
| Q2 2019 | $904,000 | +142.4% | 22,590 | +152.8% | 0.01% | +160.0% |
| Q1 2019 | $373,000 | – | 8,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |